UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.55 -1.08 (-1.31%) GOLD FUTURES
2,297.30 -60.40 (-2.56%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,166.84 -2,226.23 (-4.42%)
Chugai Pharmaceutical Co., Ltd. (CHGCF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:40PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 50.45B |
| Enterprise value | 45.62B |
| Trailing P/E | 25.89 |
| Forward P/E | 24.10 |
| PEG ratio (5-yr expected) | 7.30 |
| Price/sales (ttm) | 8.16 |
| Price/book (mrq) | 5.15 |
| Enterprise value/revenue | 0.04 |
| Enterprise value/EBITDA | 0.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.48 |
| 52-week change 3 | 24.73% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 43.72 |
| 52-week low 3 | 26.00 |
| 50-day moving average 3 | 37.87 |
| 200-day moving average 3 | 33.58 |
Share statistics
| Avg vol (3-month) 3 | 490 |
| Avg vol (10-day) 3 | 270 |
| Shares outstanding 5 | 1.65B |
| Implied shares outstanding 6 | 1.69B |
| Float 8 | 639.35M |
| % held by insiders 1 | 59.91% |
| % held by institutions 1 | 18.92% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.56 |
| Forward annual dividend yield 4 | 1.72% |
| Trailing annual dividend rate 3 | 80.00 |
| Trailing annual dividend yield 3 | 246.69% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 40.33% |
| Dividend date 3 | 01 Sept 2017 |
| Ex-dividend date 4 | 27 Jun 2024 |
| Last split factor 2 | 3:1 |
| Last split date 3 | 29 Jun 2020 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 31.50% |
| Operating margin (ttm) | 42.15% |
Management effectiveness
| Return on assets (ttm) | 15.01% |
| Return on equity (ttm) | 21.20% |
Income statement
| Revenue (ttm) | 1.04T |
| Revenue per share (ttm) | 629.73 |
| Quarterly revenue growth (yoy) | -24.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 467.56B |
| Net income avi to common (ttm) | 326.37B |
| Diluted EPS (ttm) | 1.25 |
| Quarterly earnings growth (yoy) | 1.20% |
Balance sheet
| Total cash (mrq) | 764.57B |
| Total cash per share (mrq) | 464.67 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 5.53 |
| Book value per share (mrq) | 997.97 |
Cash flow statement
| Operating cash flow (ttm) | 383.09B |
| Levered free cash flow (ttm) | 287.75B |
© 2024 Yahoo. All rights reserved.